Morihito Okada

Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.

S. Oizumi, Y. Ohde, K. Takamochi, 2023, Cancer science.

Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations.

M. Okada, N. Tsubota, M. Yoshimura, 2000, Chest.

Operative approach for multiple primary lung carcinomas.

M. Okada, N. Tsubota, M. Yoshimura, 1998, The Journal of thoracic and cardiovascular surgery.

How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer.

M. Okada, N. Tsubota, M. Yoshimura, 1999, The Annals of thoracic surgery.

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy.

M. Okada, N. Tsubota, M. Yoshimura, 2000, The Journal of thoracic and cardiovascular surgery.

Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL)

Y. Miyata, Y. Yamashita, Yasuhiro Tsutani, 2024, Cancers.

The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer

Y. Miyata, T. Mimae, N. Tsubokawa, 2024, Annals of surgical oncology.

Effectiveness of pleurodesis for postoperative air leaks after lung resection

Y. Miyata, T. Mimae, N. Tsubokawa, 2024, Journal of cardiothoracic surgery.